Tanomastat
- Level
- Commodity
- Parent
- 51343700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343701This classification denotes a matrix metalloproteinase inhibitor with the molecular formula C23H19ClO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AM1ZX94EXH, chemically known as (s)-4-chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1-biphenyl)-4-butanoic acid but generally known as tanomastat, which bears US NIH Compound Identifier 177347. The term TANOMASTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule Tanomastat under HS 29309085 and SITC 51549. As of Q4 2014, TANOMASTAT remains the US FDA Preferred Term for this commodity. Tanomastat bears US NLM identifiers UMLS ID C0393069 and NCI Concept Code C1705. SMILES: C1CCC(CC1)SC[C@@H](CC(=O)C2CCC(CC2)C3CCC(CC3)CL)C(=O)O.
Same parent
Under 51343700 · 5Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.